Press release
Global Pars Planitis Treatment Market Projected to Grow at 7.7% CAGR, Reaching $920.48 Billion by 2029
Pars Planitis Treatment
What Will the Pars Planitis Treatment Industry Market Size Be by 2025?
In the past, the market size for the treatment of pars planitis has seen substantial expansion. The market value is poised to increase from $632.88 billion in 2024 to $683.54 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. This considerable growth within the historical period can be credited to factors such as growing knowledge regarding autoimmune eye conditions, the escalating occurrence of uveitis among children, expanded accessibility to ophthalmic care, the broader application of immunosuppressants, and rising patient comprehension of the importance of early intervention.
What's the Long-Term Growth Forecast for the Pars Planitis Treatment Market Size Through 2029?
In the coming years, significant growth is anticipated in the pars planitis treatment market size. It's predicted to expand to $920.48 billion in 2029 with a 7.7% compound annual growth rate (CAGR). Factors contributing to the market growth during the forecast period include an increase in the use of biologic therapies, a higher prevalence of autoimmune diseases, an emphasis on pediatric eye care, broader health insurance coverage, and a surge in the demand for personalized treatment. The foreseeable future showcases trends such as a shift towards steroid-sparing therapies, the incorporation of teleophthalmology, the creation of long-lasting implants, usage of biosimilars in treatment, and an increase in combination therapy.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pars-planitis-treatment-global-market-report
What Are the Key Growth Drivers Fueling the Pars Planitis Treatment Market Expansion?
The escalation in cases of pars planitis is anticipated to spur the expansion of the pars planitis treatment market. Pars planitis is an idiopathic type of intermediate uveitis that primarily triggers inflammation in the vitreous and peripheral retina, generally affecting those aged between 15 to 40. The upward trend in pars planitis incidences can be attributed to heightened awareness and enhanced diagnostic capabilities, with cutting-edge imaging tools facilitating earlier and more precise detection. Treatments for pars planitis aid in managing the condition by diminishing ocular inflammation - a crucial element in maintaining vision and avoiding complications. These treatments improve patient care through specialised therapies such as corticosteroids and immunosuppressants, thus elevating long-term ocular health and life quality. For instance, as per a case report published by Mega Journal of Case Reports, a US-based medical journal, in February 2025, intermediate uveitis occurs at a rate of 1.4 to 2 cases per 100,000 individuals, with pars planitis, the idiopathic form, making up 70% of these cases. Hence, the escalating incidence of pars planitis fuels the growth of the pars planitis treatment market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24649&type=smp
What Are the Key Trends Driving Pars Planitis Treatment Market Growth?
Significant businesses in the pars planitis treatment market are channeling their efforts into developing groundbreaking solutions such as bispecific antibodies. These are designed to enhance immune modulation, curb ocular inflammation, and limit systemic side effects. Bispecific antibodies are specially engineered proteins programmed to attach simultaneously to two different antigens or targets, delivering a more accurate and effective treatment with minimal side effects. Take for example Genentech Inc., a US-based biotech firm that in October 2023 earned FDA approval for Vabysmo (faricimab-svoa). This medication is used to treat retinal vein occlusion (RVO), age-related macular degeneration, and diabetic macular edema. Vabysmo is the inaugural bispecific antibody used in ophthalmology that aims at both Angiopoietin-2 (Ang-2) and vascular endothelial growth factor A (VEGF-A), concurrently dealing with inflammation and vascular leakage. This innovative strategy is being investigated for use in intermediate uveitis, particularly pars planitis, a condition that necessitates durable and focused intervention due to chronic inflammation in the retinal periphery.
How Is the Pars Planitis Treatment Market Segmented?
The pars planitis treatment market covered in this report is segmented -
1) By Treatment: Corticosteroid, Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Surgery, Cryotherapy, Immunomodulatory Therapy, Other Treatments
2) By Diagnosis: Blood Tests, X-ray, Magnetic Resonance Imaging (MRI), Other Diagnosis
3) By Route Of Administration: Oral, Intravenous, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy
5) By End-User: Clinic, Hospital, Other End-Users
Subsegments:
1) By Corticosteroid: Topical Corticosteroids, Periocular Corticosteroid Injections, Intravitreal Corticosteroid Implants, Systemic Corticosteroids
2) By Non-Steroidal Anti-Inflammatory Drugs (NSAIDs): Oral Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Injectable Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
3) By Surgery: Pars Plana Vitrectomy, Cataract Surgery, Glaucoma Surgery
4) By Cryotherapy: Trans-scleral Cryotherapy, Endocryotherapy
5) By Immunomodulatory Therapy: Antimetabolites, Calcineurin Inhibitors, Biologic Agents
6) By Other Treatments: Antibiotics, Antivirals, Laser therapy
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=24649&type=smp
Which Companies Are Leading the Charge in Pars Planitis Treatment Market Innovation?
Major companies operating in the pars planitis treatment market are Johnson & Johnson, Merck & Co Inc., AbbVie Inc., Bayer AG, AstraZeneca plc, Novartis AG, EyePoint Pharmaceuticals Inc., Medtronic plc, Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Quantum Cryogenics Ltd., Zimmer MedizinSysteme GmbH, Sun Pharmaceutical Industries Ltd., Hologic Inc., Aurobindo Pharma Limited, Santen Pharmaceutical Co. Ltd., CooperSurgical Inc., AtriCure Inc., Alimera Sciences Inc., Clearside Biomedical Inc.
Which Regions Are Leading the Global Pars Planitis Treatment Market in Revenue?
North America was the largest region in the pars planitis treatment market in 2024. The regions covered in the pars planitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase the full report to*day:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24649
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Learn More About The Business Research Company
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pars Planitis Treatment Market Projected to Grow at 7.7% CAGR, Reaching $920.48 Billion by 2029 here
News-ID: 4092485 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for Treatment
Trigeminal Neuralgia Treatment Market Size, Trigeminal Neuralgia Treatment Marke …
Trigeminal Neuralgia Treatment Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Trigeminal Neuralgia Treatment research data, benefit, gross margin, worldwide market…
Medical Tourism Market Report by Treatment Type (Dental Treatment, Cosmetic Trea …
The global medical tourism market accounted for $104.68 billion in 2019, and is projected to reach $273.72 billion by 2027, registering a CAGR of 12.8% from 2019 to 2027 in terms of value.
View Full Report: https://reports.valuates.com/market-reports/ALLI-Auto-0P310/medical-tourism
In terms of volume, the global medical tourism market accounted for 23,042.90 thousand patients in 2019, and is projected to reach 70,358.61 thousand patients by 2027, registering a CAGR of 15.0% from 2019 to…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Stretch Marks Treatment Market by Treatment & Forecast - 2025
Global Stretch Marks Treatment Market: Snapshot
In order to expand their outreach and add to their product portfolio, keen players in the global stretch marks treatment market are taking the inorganic route of acquisitions. They are also pouring money into development of new and better products.
Rising instances of obesity causing stretch marks is serving to catalyze growth in the market. In addition, growing aesthetic consciousness among people, especially among pregnant women,…
Medical Tourism Market by Treatment Type (Dental Treatment, Cosmetic Treatment, …
Medical Tourism Market Overview:
The global medical tourism market was valued at $53,768 million in 2017, and is estimated to reach at $143,461 million by 2025, registering a CAGR of 12.9% from 2018 to 2025.
Organized travel across international borders to avail medical treatment of some form, which may or may not be available in the travelers home country is defined as medical tourism. Medical tourists travel abroad for the maintenance, enhancement,…
Substance Use Disorder Treatment Market By Type (Alcohol abuse treatment, Nicoti …
According to World Health Organization (WHO), the leading cause of disability around the world is not a physical disease, but a serious mood disorder known as depression. Around 350 million people suffer from depression worldwide, and that only about 50% of these individuals will ever receive treatment. According to Anxiety and Depression Association of America, in the U.S., over 15 million adults experience an episode of clinical depression in any…
